C10016725 / invoice 10000
Species:FELINE
Breed:Domestic Medium Hair
Age (years):0
Diagnosis or signs:Hospitalisation from Toxicity
Consult notes
Animal clinical history (3 most recent)
2026-03-06T00:00:00Z 2:12 PM
Weight: 2.83 kgSubjective- Presented for potential toxin ingestion this morning.- The kitten pierced the owner's Vyvanse (lisdexamfetamine) 40 mg capsules. The capsule was pierced, not swallowed, but he may have ingested some powder.- Owner brought the kitten in for prophylactic treatment due to the high toxicity of dextroamphetamine in felines.Objective- Temperature: 38.7°C- Pulse: 156 bpm- Respiration: 35 bpm- Mucous membranes: Pink and moist- Capillary refill time: <2 seconds- Demeanour: Bright, alert, responsive. H 4+.- BCS: 5/9, Hydration: Clinically adequate.- Exam: - Cardiovascular: Normal auscultation, no murmur or arrhythmia. - Respiratory: Thoracic auscultation clear bilaterally, normal respiratory effort. - Oral: No cleft palate, otherwise unremarkable. - Abdominal: Non-painful on palpation. NAD. - Musculoskeletal: Ambulating normally, no pain on palpation. - Integument/Ears: Ears clean, skin unremarkable. - Other systems: Neurologically, lymph nodes, eyes all NSF.Assessment- Suspected dextroamphetamine toxicity.Plan- Hospitalisation: Admitted for day-stay for monitoring and management.- Intravenous Fluids: Hartmann's solution administered intravenously at a rate of 8.4 ml/hr.- Decontamination: Activated charcoal administered orally (2 g/kg dose, 5 g total). Three doses were administered in hospital, one dose was sent home with the owners to administer at night.- Monitoring: Closely monitored for signs of toxicity throughout the day, including CNS, cardiovascular, and gastrointestinal signs. None evident.Discharge Instructions: - Counselled owner on potential toxic effects and clinical signs to monitor for at home. - Signs include: agitation, hyperactivity, restlessness, tremors, seizures, confusion, head bobbing, stereotypic behaviours, tachycardia, panting, drooling, vomiting, hypersalivation, diarrhoea, mydriasis, hyperthermia, aggression, vocalisation, or paradoxical sedation. - Instructed owner to administer one further dose of activated charcoal at home. - Advised owner to seek immediate veterinary attention if any clinical signs develop. Vital Signs
Previous claim history (2)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-02-13 | C09897531 | VACCINATIONS |
| 2026-02-13 | C09897551 | VACCINATIONS OR HEALTH CHECKS |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_hospitalisation | 25.51 | 2026-03-06 | — |
| 20000 | tstarc_hospitalisation | 28.22 | 2026-03-06 | — |
| 30000 | tstarc_hospitalisation | 45.57 | 2026-03-06 | — |
| 40000 | tstarc_consultation | 73.50 | 2026-03-06 | — |
| 50000 | tstarc_activated_charcoal | 21.70 | 2026-03-06 | — |
UPM+
- DG02034INTOXICATION (POISONING)/TOXIN EXPOSURE - PRESENTING COMPLAINTDSTP_toxicity_-_unspecified
Variant (sleepy_king)
INTOXICATION (POISONING)/TOXIN EXPOSURE - PRESENTING COMPLAINT
DSTP_toxicity_-_unspecified
Conf: 0.760
Threshold: 0.21
Above: ✓
Correct?